Cargando…

Exploring the potential of contrast agents in breast cancer echography: current state and future directions

Breast cancer stands as the most frequent malignancy and leading cause of death among women. Early and accurate detection of this pathology represents a crucial factor in enhancing both incidence and mortality rates. Ultrasound (US) examination has been extensively adopted in clinical practice due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Monzeglio, Oriana, Melissa, Vittoria Maria, Rodolfi, Sara, Valentini, Eleonora, Carriero, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632334/
https://www.ncbi.nlm.nih.gov/pubmed/37566194
http://dx.doi.org/10.1007/s40477-023-00809-0
_version_ 1785146137708068864
author Monzeglio, Oriana
Melissa, Vittoria Maria
Rodolfi, Sara
Valentini, Eleonora
Carriero, Alessandro
author_facet Monzeglio, Oriana
Melissa, Vittoria Maria
Rodolfi, Sara
Valentini, Eleonora
Carriero, Alessandro
author_sort Monzeglio, Oriana
collection PubMed
description Breast cancer stands as the most frequent malignancy and leading cause of death among women. Early and accurate detection of this pathology represents a crucial factor in enhancing both incidence and mortality rates. Ultrasound (US) examination has been extensively adopted in clinical practice due to its non-invasiveness, affordability, ease of implementation, and wide accessibility, thus representing a valuable first-line diagnostic tool for the study of the mammary gland. In this scenario, recent developments in nanomedicine are paving the way for new interpretations and applications of US diagnostics, which are becoming increasingly personalized based on the molecular phenotype of each tumor, allowing for more precise and accurate evaluations. This review highlights the current state-of-the-art of US diagnosis of breast cancer, as well as the recent advancements related to the application of US contrast agents to the field of molecular diagnostics, still under preclinical study.
format Online
Article
Text
id pubmed-10632334
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106323342023-11-15 Exploring the potential of contrast agents in breast cancer echography: current state and future directions Monzeglio, Oriana Melissa, Vittoria Maria Rodolfi, Sara Valentini, Eleonora Carriero, Alessandro J Ultrasound Review Paper Breast cancer stands as the most frequent malignancy and leading cause of death among women. Early and accurate detection of this pathology represents a crucial factor in enhancing both incidence and mortality rates. Ultrasound (US) examination has been extensively adopted in clinical practice due to its non-invasiveness, affordability, ease of implementation, and wide accessibility, thus representing a valuable first-line diagnostic tool for the study of the mammary gland. In this scenario, recent developments in nanomedicine are paving the way for new interpretations and applications of US diagnostics, which are becoming increasingly personalized based on the molecular phenotype of each tumor, allowing for more precise and accurate evaluations. This review highlights the current state-of-the-art of US diagnosis of breast cancer, as well as the recent advancements related to the application of US contrast agents to the field of molecular diagnostics, still under preclinical study. Springer International Publishing 2023-08-11 /pmc/articles/PMC10632334/ /pubmed/37566194 http://dx.doi.org/10.1007/s40477-023-00809-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Paper
Monzeglio, Oriana
Melissa, Vittoria Maria
Rodolfi, Sara
Valentini, Eleonora
Carriero, Alessandro
Exploring the potential of contrast agents in breast cancer echography: current state and future directions
title Exploring the potential of contrast agents in breast cancer echography: current state and future directions
title_full Exploring the potential of contrast agents in breast cancer echography: current state and future directions
title_fullStr Exploring the potential of contrast agents in breast cancer echography: current state and future directions
title_full_unstemmed Exploring the potential of contrast agents in breast cancer echography: current state and future directions
title_short Exploring the potential of contrast agents in breast cancer echography: current state and future directions
title_sort exploring the potential of contrast agents in breast cancer echography: current state and future directions
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632334/
https://www.ncbi.nlm.nih.gov/pubmed/37566194
http://dx.doi.org/10.1007/s40477-023-00809-0
work_keys_str_mv AT monzegliooriana exploringthepotentialofcontrastagentsinbreastcancerechographycurrentstateandfuturedirections
AT melissavittoriamaria exploringthepotentialofcontrastagentsinbreastcancerechographycurrentstateandfuturedirections
AT rodolfisara exploringthepotentialofcontrastagentsinbreastcancerechographycurrentstateandfuturedirections
AT valentinieleonora exploringthepotentialofcontrastagentsinbreastcancerechographycurrentstateandfuturedirections
AT carrieroalessandro exploringthepotentialofcontrastagentsinbreastcancerechographycurrentstateandfuturedirections